By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Synthetic Genomics, Inc. 

11149 North Torrey Pines Road

La Jolla  California  92037  U.S.A.
Phone: 858-754-2900 Fax: 858-754-2988


SEARCH JOBS

Synthetic Genomics Inc. was founded to commercialize genomic-driven technologies. Our scientific strength lies in the decades of pioneering research by founders, J. Craig Venter, Ph.D., Nobel Laureate Hamilton O. Smith, M.D., and the leading scientific teams they have assembled. Dr. Venter and his teams have proven track records of making scientific breakthroughs that translate into viable commercial solutions.

The company's scientific capabilities encompass areas such as environmental genomics, microbiology, biochemistry, bioinformatics, plant genomics, genome engineering, synthetic biology, and climate change. In addition to the strong applied research efforts conducted at SGI, the company sponsors fundamental research at the J. Craig Venter Institute, a not-for-profit organization with more than 400 scientists and staff working on a variety of genomic research and policy fronts. In addition to the Intellectual Property developed internally, SGI has exclusive access to new inventions and discoveries in synthetic genomics research developed by the JCVI under the Sponsored Research Agreement between both organizations.


Key Statistics


Email: syntheticgenomics.com
Ownership: Private

Web Site: Synthetic Genomics, Inc.
Employees:
Symbol: 
 



Industry
Biotechnology

Segment
Genomics
Start Up





Company News
SGI-DNA, A Synthetic Genomics, Inc. Company, Announces Exclusive Global Distribution Agreement For Reagents With VWR 7/20/2016 7:30:26 AM
First Minimal Synthetic Bacterial Cell Designed And Constructed By Scientists At Venter Institute And Synthetic Genomics, Inc. 3/25/2016 6:17:32 AM
Synthetic Genomics, Inc. To Present At The J.P. Morgan 34th Annual Healthcare Conference 1/6/2016 10:58:37 AM
Synthetic Genomics, Inc. Expands Collaborative Research And Development Agreement With Lung Biotechnology PBC, A Subsidiary Of United Therapeutics (UTHR), To Develop Organs For Transplantation 9/23/2015 11:21:46 AM
Synthetic Genomics, Inc. And Gen9 Sign Licensing Agreement For Synthetic Biology Technology Patents 6/11/2015 11:27:08 AM
Synthetic Genomics, Inc. Release: SGI-DNA Launches Gibson Assembly® Ultra Kit For Robust, Seamless And Efficient Construction Of Synthetic Genes, Genetic Pathways And Whole Genomes 1/21/2015 11:12:20 AM
Synthetic Genomics, Inc. Appoints Oliver Fetzer, Ph.D., MBA As Chief Executive Officer 10/28/2014 6:12:17 AM
Avoca Signs Supply Agreement With Synthetic Genomics, Inc. To Become Domestic Source Of Natural Astaxanthin 6/20/2014 8:20:20 AM
Synthetic Genomics, Inc. Research Team Publishes New Methods for Synthetic Generation of Influenza Vaccines 5/16/2013 9:44:46 AM
SGI-DNA, a New Subsidiary of Synthetic Genomics, Inc., and Integrated DNA Technologies Announce Broader Collaboration to Develop, Manufacture, and Market Synthetic DNA Products 2/27/2013 10:13:57 AM
123
//-->